Medications

Rapivab approved to help treat flu

(HealthDay)—Rapivab (peramivir) has been approved by the U.S. Food and Drug Administration to treat influenza.

Medications

FDA approves AbbVie combo hepatitis C treatment

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

Medications

Drug shortage crisis puts public health at risk

Hospitals and pharmacies around the country are facing severe shortages of essential drugs. These shortages can limit access to critical medications and compromise patient safety, resulting in serious illness and even death. ...

Medications

Bristol-Myers: FDA blocks hepatitis C drug for now

U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir.

Medications

Gilead to license generic version of Sovaldi (Update)

Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.

page 38 from 40